Navigation Links
Stereotaxis Announces Fourth Quarter and Full Year 2008 Earnings Release Date and Conference Call
Date:2/6/2009

ST. LOUIS, Feb. 6 /PRNewswire-FirstCall/ -- Stereotaxis, Inc. (Nasdaq: STXS) announced today that it will release its financial results for the fourth quarter and full year ended December 31, 2008, on Thursday, February 26, 2009 before the market opens. The Company will host a conference call and webcast on Thursday, February 26, 2009 at 8:30 a.m. Eastern Time to discuss the Company's fourth quarter results and current corporate developments. The dial-in number for the conference call is 800-240-2134 for domestic participants and 303-275-2170 for international participants.

A taped replay of the conference call will also be available beginning approximately one hour after the call's conclusion and will be available for seven days. This replay can be accessed by dialing 800-405-2236 for domestic callers and 303-590-3000 for international callers, both using passcode 11125670#. The call will also be available on the Internet live and 90 days thereafter at the following URL: http://www.videonewswire.com/event.asp?id=55849

About Stereotaxis

Stereotaxis designs, manufactures and markets an advanced cardiology instrument control system for use in a hospital's interventional surgical suite to enhance the treatment of coronary artery disease and arrhythmias. The Stereotaxis System is designed to enable physicians to complete more complex interventional procedures by providing image guided delivery of catheters and guidewires through the blood vessels and chambers of the heart to treatment sites. This is achieved using computer-controlled, externally applied magnetic fields that govern the motion of the working tip of the catheter or guidewire, resulting in improved navigation, shorter procedure time and reduced x-ray exposure.
'/>"/>

SOURCE Stereotaxis, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Stereotaxis Showcases Advancements for Remote Magnetic Ablations
2. Stereotaxis Appoints Senior Vice President, North America
3. Stereotaxis to Present at the Seventh Annual JMP Securities Research Conference
4. Stereotaxis Market Leadership Highlighted at Heart Rhythm 2008
5. Stereotaxis Highlights a Transatlantic Arrhythmia Procedure Collaboration With the Odyssey(TM) Network
6. Stereotaxis Reports Fourth Quarter and Full Year 2007 Financial Results
7. Stereotaxis Appoints David Burkhardt, M.D. as Chief Medical Officer
8. Stereotaxis Announces FDA Approval of Its Partnered Magnetic Irrigated Catheter
9. Stereotaxis Niobe System Used to Perform More Than 10,000 Procedures Worldwide
10. Amicus Therapeutics Announces Fourth Quarter and Full Year 2008 Financial Results
11. Hoya Announces Third Quarter and the First Nine Months Financial Results for FY2008
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/18/2013)... electric cars could be on roads across North America before ... by the United States Department of Energy, Los Alamos National ... is part of a team led by the Los Alamos ... expensive platinum catalysts in fuel cells. , "One of the ... is the cost of the units. The pure platinum needed ...
(Date:6/18/2013)... 2013 In support of Swiss contributions ... General of Switzerland in New York is pleased to ... Tûranor PlanetSolar , to Manhattan. PlanetSolar is in ... 2013 tour with scientists on board from the University ... runs exclusively on energy from the sun and eliminates ...
(Date:6/18/2013)... June 18, 2013 The Regulatory ... of two new offices in Asia—one in Singapore and ... serve as RAPS’ Pan-Asia office , serving the ... more focused on audiences within China. , The announcement ... partnership with five Singapore government agencies to develop and ...
(Date:6/18/2013)... 2013 The human skin is the largest ... important human body part. Similar to the liver, or heart, ... function, repair and grow. Recent reports from the mankatofreepress.com explained ... just as important as other life supporting organs. The article ... skin cell reproduction, increase the appearance of skin, and fight ...
Breaking Biology Technology:US and Canadian researchers drive towards cheaper fuel cells for electric cars 2Switzerland’s MS Tûranor PlanetSolar, the World’s Largest Solar Boat, Arrives in New York City 2Switzerland’s MS Tûranor PlanetSolar, the World’s Largest Solar Boat, Arrives in New York City 3Switzerland’s MS Tûranor PlanetSolar, the World’s Largest Solar Boat, Arrives in New York City 4RAPS Opens Offices in Singapore and China 2RAPS Opens Offices in Singapore and China 3Natural Acne Remedies Through Diet, Probiotic Action Shares New Insight on What Foods May Help Lead to Clear Skin 2
... University in St. Louis have developed a technique for ... and two to five times more effective than commercial ... effective fuel cell technology, which has been waiting in ... for cleaner use of fuels worldwide. , Younan ...
... WA and VANCOUVER, May 14 /PRNewswire-FirstCall/ - OncoGenex Pharmaceuticals, ... release of two abstracts to be presented during oral ... (ASCO) Annual Meeting. Abstracts are now available to the ... www.oncogenex.com in addition to the ASCO Web site, ...
... Bayer HealthCare Pharmaceuticals, Inc. and Onyx Pharmaceuticals, Inc. ... than 65 studies evaluating the use of Nexavar(R) (sorafenib) ... of Clinical Oncology (ASCO) annual meeting."Nexavar has a proven ... of unresectable hepatocellular carcinoma (HCC), or liver cancer, and ...
Cached Biology Technology:New fuel cell catalyst uses 2 metals 2New fuel cell catalyst uses 2 metals 3OncoGenex Pharmaceuticals Announces Release of Two ASCO Abstracts: Impact of OGX-011 on Survival in Randomized Phase 2 Trial and Phase 1 Safety Data for OGX-427 2OncoGenex Pharmaceuticals Announces Release of Two ASCO Abstracts: Impact of OGX-011 on Survival in Randomized Phase 2 Trial and Phase 1 Safety Data for OGX-427 3OncoGenex Pharmaceuticals Announces Release of Two ASCO Abstracts: Impact of OGX-011 on Survival in Randomized Phase 2 Trial and Phase 1 Safety Data for OGX-427 4OncoGenex Pharmaceuticals Announces Release of Two ASCO Abstracts: Impact of OGX-011 on Survival in Randomized Phase 2 Trial and Phase 1 Safety Data for OGX-427 5Bayer and Onyx Announce Nexavar Data Presentations at 45th American Society of Clinical Oncology Annual Meeting 2Bayer and Onyx Announce Nexavar Data Presentations at 45th American Society of Clinical Oncology Annual Meeting 3Bayer and Onyx Announce Nexavar Data Presentations at 45th American Society of Clinical Oncology Annual Meeting 4Bayer and Onyx Announce Nexavar Data Presentations at 45th American Society of Clinical Oncology Annual Meeting 5Bayer and Onyx Announce Nexavar Data Presentations at 45th American Society of Clinical Oncology Annual Meeting 6
(Date:6/18/2013)... is estimated that between 5% and 10% of breast ... to say that these tumours are attributable to inherited ... or BRCA2. In patients with these mutations, PARP inhibitors, ... results that make them a new option for personalised ... latest studies indicate that a fraction of these patients ...
(Date:6/18/2013)... A team of internationally recognized feline experts including veterinarians ... the University of Lincoln, U.K. and Dr Ilona Rodan, ... by the International Society of Feline Medicine (ISFM) and ... guidelines for veterinarians, owners and those working with cats ... domestic cat. The new guidelines appear in the ...
(Date:6/17/2013)... Boston, MA Women in the U.S. exposed to high ... as likely to have a child with autism as women ... new study from Harvard School of Public Health (HSPH). It ... autism and air pollution across the U.S. , "Our findings ... of the women in our study lived in areas where ...
Breaking Biology News(10 mins):An article in 'Cell' reveals a new resistance mechanism to chemotherapy in breast and ovarian cancer 2Feline behavior experts release guidelines to improve the welfare of cats 2Exposure to high pollution levels during pregnancy may increase risk of having child with autism 2
... made to enhance memory appears to trigger a natural mechanism ... after the drug itself has left the body, according to ... Lynch, along with Associate Researcher Julie Lauterborn, were among a ... class of drugs known as ampakines. Ampakines were developed in ...
... widely used group of insecticides can mix with and ... according to a new study led by biologists at ... in toxicity was relatively modest, the effects from the ... The study's results, reported in the July 26 online ...
... MD, so overjoyed are they at hearing her words. What ... Indulge your passion for spicy cuisine. Drink red wine. Enjoy ... breakfast and, what the heck, eat a grapefruit, too. Gerson ... support the notion that eating these foods will make heartburn ...
Cached Biology News:Drug triggers body's mechanism to reverse aging effect on memory process 2Mosquito spray increases toxicity of pyrethroids in creek, study finds 2Mosquito spray increases toxicity of pyrethroids in creek, study finds 3Mosquito spray increases toxicity of pyrethroids in creek, study finds 4Chocolate, wine, spicy foods may be OK for heartburn, Stanford study finds 2Chocolate, wine, spicy foods may be OK for heartburn, Stanford study finds 3Chocolate, wine, spicy foods may be OK for heartburn, Stanford study finds 4
... George Paxinos Affiliation: School of Psychology, The ... Watson Affiliation: Curtin University of Technology, Perth, Australia ... atlas of the rat brain. It is ... mm) revison and extension of the compact 3rd ...
The PxE Thermal Cycler (PxE) is a licensed 96 well PCR machine, developed to provide all fundamental features for value for money thermal cycling....
Control primers and template for 5kb and 15 kb products....
Our original highly-purified, robust Taq Polymerase which delivers consistently high yields and minimal background...
Biology Products: